Drug Approval | December 12, 2024
Briefs: Alembic Pharmaceuticals and Veerhealth Care
The successful completion of RRA assessment by the USFDA, would enable company to open up its business in the USA market
The successful completion of RRA assessment by the USFDA, would enable company to open up its business in the USA market
Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC) is used to temporarily relieve itchy eyes due to pollen, ragweed, grass, animal hair and dander
Diltiazem Hydrochloride Extended-Release Capsules USP are indicated for the treatment of hypertension
US Generics grew 5% to Rs. 467 Crores for the quarter
Diltiazem Hydrochloride Extended-Release Capsules USP are indicated for the treatment of hypertension
Mylan and Novo Nordisk reach settlement of US patent litigation related to Ozempic
Alcaftadine Ophthalmic Solution, 0.25% (OTC) is used to temporarily relieve itchy eyes due to pollen, ragweed, grass, animal hair, and dander
Lamotrigine extended-release tablets are indicated for adjunctive therapy for primary generalized tonic-clonic seizures and partial-onset seizures
Lupin's Pithampur Unit-1 gets Form 483 from USFDA with 3 observations
Paliperidone extended-release tablets are an atypical antipsychotic agent indicated for treatment of schizophrenia
Subscribe To Our Newsletter & Stay Updated
